Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogs, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral drugs by targeting the viral polymerases. However, the underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Qi, Peng, Ruchao, Yuan, Bin, Wang, Min, Zhao, Jingru, Fu, Lifeng, Qi, Jianxun, Shi, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834001/
https://www.ncbi.nlm.nih.gov/pubmed/33521757
http://dx.doi.org/10.1016/j.xinn.2021.100080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834001/
https://www.ncbi.nlm.nih.gov/pubmed/33521757
http://dx.doi.org/10.1016/j.xinn.2021.100080

Ejemplares similares